Forbes February 3, 2023
Joshua Cohen

Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.

By paying a monthly flat fee of $5 an Amazon Prime members can obtain as many generic drugs as they need, among an initial set of 50 medications indicated for conditions, such as high blood pressure, anxiety, and male pattern baldness. Amazon’s new initiative will operate within its existing pharmacy infrastructure and distribution channels.

Paying a low, flat cash rate for generics isn’t unprecedented. Walmart, among others, has such a program.

And, for two years Mark Cuban’s Cost Plus Drug Company (MCCPDC) has been making waves in the cash business for generic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
New drug delivery method promises long-lasting glaucoma relief
Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans
Pharma Pulse 2/14/25: Building Confidence in CGT Innovation, The Power of PBMs and Biosimilars & more
Preparing for Potential Vaccine Regulatory Changes
Novartis to acquire Anthos Therapeutics in deal worth up to $3.1 billion

Share This Article